Other
Efficacy
0
Pipeline Programs↗
158
Active Trials↗
199
Companies Involved↗
Efficacy is an early-stage landscape with 0 programs across 199 companies. The most active players are Novartis, GSK, AstraZeneca.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
1,199
clinical trials
Completed760 · 63%
Unknown status139 · 12%
Terminated91 · 8%
Recruiting76 · 6%
Not yet recruiting45 · 4%
Withdrawn45 · 4%
Other43 · 4%
Clinical Trials
Trial Activity
1199 trials
Efficacy, Safety and Pharmacokinetics of DTG with RIF
Recruiting·TThe HIV Netherlands Australia Thailand Research Collaboration·Phase 2·NCT03731559·200 enrolled
A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
Recruiting·—·Phase 2·NCT06509984·20 enrolled
Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis
Recruiting·—·Phase 4·NCT07342153·126 enrolled
Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety
Recruiting·—·Phase 1·NCT07453862·20 enrolled
Page 1 of 80
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)